Pfizer Products Inc v Global Exporters Limited

Pfizer Products Inc and Global Exporters Limited were parties to proceedings before the Federal Court of Australia concerning alleged breaches of intellectual property rights. The dispute centred on Global Exporters Limited's importation and sale of pharmaceutical products that Pfizer Products Inc claimed infringed its registered trademarks and patent rights. Pfizer sought injunctive relief and damages for the alleged contraventions.

The primary legal issues before the Court were whether Global Exporters Limited had infringed Pfizer Products Inc's registered trademarks by importing and selling goods bearing identical or substantially identical marks to those registered by Pfizer, and whether the importation and sale of these goods constituted an infringement of Pfizer's Australian patent. The Court was required to consider the scope of trademark rights in relation to parallel importation and the principles of patent infringement in the context of imported goods.

Justice Kirov considered the evidence presented by both parties regarding the origin of the goods, the trademarks affixed to them, and the relevant patent claims. The Court applied established principles of trademark law, including the test for infringement, which involves assessing whether the marks are identical or deceptively similar and whether the use is in relation to goods or services for which the mark is registered. Regarding the patent infringement claim, the Court examined whether the imported products fell within the scope of the claims of Pfizer's patent. The Court's reasoning focused on the statutory provisions governing trademark and patent infringement in Australia and the relevant case law interpreting these provisions.